Target intelligence / Profile preview

Inhibitor of growth protein 1 (ING1)

Target
ING1
Molecular classification
Transcription factor, Epigenetic regulator, Histone modification reader, Tumor suppressor protein
01

Overview

Inhibitor of growth protein 1 (ING1) is a nuclear tumor suppressor protein encoded by the ING1 gene, which regulates diverse cellular processes including cell cycle arrest, apoptosis, senescence, and DNA repair through pathways involving both p53-dependent and p53-independent mechanisms[1][2][3]. ING1 acts as a chromatin-associated transcription factor and epigenetic regulator, interacting with histone deacetylase complexes and binding to methylated histones[1][4][5]. Deficiency or downregulation of ING1 is observed in many cancers, and its physiological roles span inhibition of cell growth, promotion of apoptosis, and suppression of tumorigenesis, particularly in lymphoid and epithelial tissues[2][3][5]. ING1 modulates DNA damage responses and interacts with a range of partners including p53, PCNA, HDAC1, and pro-apoptotic BCL2 family members[1][4]. ING1 is a member of the broader ING family, with several alternatively spliced isoforms documented.

Other names
p33ING1p33ING1bp24ING1cp47p47ING1aINhibitor of growth 1growth inhibitor ING1growth inhibitory protein ING1tumor suppressor ING1p33inhibitor of growth protein 1
02

Biological functions

Cell cycle regulationApoptosisDNA repairRegulation of cell proliferationCellular senescenceChromatin remodeling
03

Disease associations

Cancer (notably breast, liver, lung, and stomach cancers)Lymphoma (especially B-cell lymphoma)
04

Safety considerations

Targeting tumor suppressors like ING1 could potentially lead to increased cell proliferation and oncogenic risk if inhibition occurs; conversely, restoration or overexpression strategies face typical delivery and selectivity challenges.
05

Biomarkers

Reduced ING1 expression or genetic alteration may serve as a prognostic biomarker in certain cancers[5].

Beyond the preview

Go deeper on Inhibitor of growth protein 1 (ING1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor of growth protein 1 (ING1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call